SNSE- Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. (SNSE) has 6 insiders with recent SEC Form 4 filings, including 17 buys and 0 sells. SNSE is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 1.24M | $17.16M | - | |
| Pres | 220.0K | $3.05M | - | |
| 10% | 130.1K | $1.80M | -25,000 | |
| 10% | 130.1K | $1.80M | -25,000 | |
| Other | 80.0K | $1.11M | - |
Activity
Buys and sells only
Transactions
10 filings · page 4
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24, 2022 | Peyer James | Director, 10% Owner | Buy | 47,410 | $4.82 | $228,528.65 | +0.5% | -63.1% | -71.6% | |
| Jan 20, 2022 | Peyer James | Director, 10% Owner | Buy | 30,244 | $5.10 | $154,312.68 | +0.3% | -62.2% | -70.1% | |
| Jan 20, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 30,244 | $5.10 | $154,312.68 | +0.3% | -62.2% | -70.1% | |
| Jan 18, 2022 | Peyer James | Director, 10% Owner | Buy | 10,000 | $5.08 | $50,800.00 | +0.2% | -63.1% | -72.0% | |
| Jan 18, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 10,000 | $5.08 | $50,800.00 | +0.2% | -63.1% | -72.0% | |
| Jan 14, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 26,172 | $5.10 | $133,391.70 | +0.3% | -63.4% | -70.0% | |
| Jan 14, 2022 | Peyer James | Director, 10% Owner | Buy | 26,172 | $5.10 | $133,391.70 | +0.3% | -63.4% | -70.0% | |
| Jan 12, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 20,047 | $5.20 | $104,211.54 | +0.2% | -60.8% | -70.9% | |
| Jan 12, 2022 | Peyer James | Director, 10% Owner | Buy | 20,047 | $5.20 | $104,211.54 | +0.2% | -60.8% | -70.9% | |
| Jan 10, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 10,000 | $5.28 | $52,800.00 | +0.2% | -60.8% | -71.0% |